AMREP Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by AMREP Corporation on July 13, 2021, covering events occurring on July 7, 2021, and July 8, 2021. The filing primarily addresses corporate governance changes, specifically the appointment of a new director and amendments to the Company's By-Laws.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to executive compensation adjustments:
- Christopher V. Vitale (CEO): Awarded a $100,000 cash bonus and 6,000 restricted shares. Salary increased to $335,000 effective July 19, 2021.
- Adrienne M. Uleau (VP, Finance and Accounting): Awarded a $40,000 cash bonus and 2,500 restricted shares. Salary increased to $155,000 effective July 19, 2021.
Material Changes
The following material changes were reported:
- Board Appointment: Christopher V. Vitale was appointed as a member of the Board of Directors, effective July 9, 2021.
- Board Structure: The Board size was increased from three to four members. The number of Class I directors was increased from one to two.
- By-Law Amendment: Section 1(a) of Article III of the By-Laws was amended to reflect the new Board composition of four directors.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of risks and contingencies. The document focuses strictly on the execution of the Board appointment and the associated compensatory arrangements. No unusual items were disclosed.
Investor Verification Checklist
- Verify the vesting schedule for the 6,000 restricted shares awarded to Christopher V. Vitale (one-third annually from 2022 to 2024).
- Confirm the effective date of the salary increases for Mr. Vitale and Ms. Uleau (July 19, 2021).
- Review the amended By-Laws (Exhibit 3.1) to confirm the new Board structure and class definitions.
- Note that the filing does not contain updated financial statements; refer to the most recent 10-K or 10-Q for financial health.